Pulmonx annual return on equity
2020
2021
2022
2023
2024
2025
Pulmonx Return on Equity (ROE) Growth & History (LUNG)
Pulmonx's return on equity was −77.19% for fiscal 2025.
View full Pulmonx company overviewPulmonx annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −77.19% | −21.93 pp |
| 2024 | 2024-12-31 | −55.25% | −10.57 pp |
| 2023 | 2023-12-31 | −44.68% | −10.75 pp |
| 2022 | 2022-12-31 | −33.94% | −10.73 pp |
| 2021 | 2021-12-31 | −23.21% | +143.12 pp |
| 2020 | 2020-12-31 | −166.33% | — |
Pulmonx quarterly return on equity
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −23.73% | −3.05 pp |
| Q1 2026 | 2026-03-31 | −27.34% | −9.67 pp |
| Q4 2025 | 2025-12-31 | −18.27% | −3.61 pp |
| Q3 2025 | 2025-09-30 | −21.62% | −7.12 pp |
| Q2 2025 | 2025-06-30 | −20.68% | −6.20 pp |
| Q1 2025 | 2025-03-31 | −17.68% | −5.66 pp |
| Q4 2024 | 2024-12-31 | −14.66% | −3.28 pp |
| Q3 2024 | 2024-09-30 | −14.50% | −3.02 pp |
| Q2 2024 | 2024-06-30 | −14.48% | −2.82 pp |
| Q1 2024 | 2024-03-31 | −12.02% | −1.37 pp |
| Q4 2023 | 2023-12-31 | −11.38% | −2.38 pp |
| Q3 2023 | 2023-09-30 | −11.47% | −3.03 pp |
| Q2 2023 | 2023-06-30 | −11.66% | −3.39 pp |
| Q1 2023 | 2023-03-31 | −10.65% | −2.21 pp |
| Q4 2022 | 2022-12-31 | −9.00% | −2.43 pp |
| Q3 2022 | 2022-09-30 | −8.44% | −3.50 pp |
| Q2 2022 | 2022-06-30 | −8.26% | −2.16 pp |
| Q1 2022 | 2022-03-31 | −8.43% | −2.78 pp |
| Q4 2021 | 2021-12-31 | −6.57% | +90.05 pp |
| Q3 2021 | 2021-09-30 | −4.95% | — |
| Q2 2021 | 2021-06-30 | −6.10% | — |
| Q1 2021 | 2021-03-31 | −5.66% | — |
| Q4 2020 | 2020-12-31 | −96.62% | — |
Pulmonx return on equity trends
Over the last five fiscal years, Pulmonx's return on equity increased from −166.33% to −77.19%, a change of +89.14 percentage points. The latest reported quarter, Q2 2026, shows −23.73%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pulmonx source filings ↗